Health Advances (United States)

Recent papers from Health Advances (United States)

1. Limitations in US Cancer Screening Rate Data and Opportunities to Improve Precision PreventionDiagnostics · 2026
2. The baseline of fragility and capability: Hedging socio-environmental impacts of Char Dham expressway in Uttarakhand, IndiaEnvironmental and Sustainability Indicators · 2026
3. Utilization, Challenges, and Outlook of Cell of Origin Classification by Immunohistochemistry (IHC) in DLBCLDiagnostics · 2026
4. Discovery of VU6081679, a Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor 8 with Efficacy in a Preclinical Model of Parkinson’s DiseaseACS Chemical Neuroscience · 2026
5. Discovery of VU6077564: A Selective M ₁ Antagonist That Promotes Neurite Outgrowth in Adult Sensory NeuronsACS Chemical Neuroscience · 2026
6. Discovery of VU6066098: A Selective and CNS-Penetrant mGlu ₂ NAM with Robust Antidepressant-, Antipsychotic-, and Procognitive-like Activity in RodentsACS Chemical Neuroscience · 2026
7. HeatRisk and Air Quality Risk Recommendations: A Narrative Review and Action Algorithm for the Care of People at Risk for and Living with Cardiovascular DiseaseAmerican Journal of Preventive Cardiology · 2026
8. Limitations in US cancer screening rate data and opportunities for improvement.Journal of Clinical Oncology · 2026
9. Abstract 3832: Utilization, challenges, and outlook of cell of origin classification by immunohistochemistry in DLBCL: A U.S. survey of oncologists and pathologistsCancer Research · 2026
10. Precipitation Behavior of Super Duplex Stainless Steel in Friction-Stir-Welding Processes2018
11. α1-Acid Glycoprotein and Serum Amyloid A in Three Cats Suspected of Neurologic Feline Infectious PeritonitisJournal of the Japan Veterinary Medical Association · 2026
12. Numerical Analysis of Contribution to Structure-borne Sound of Each Member in Reinforced Concrete Rigid-frame ViaductsQuarterly Report of RTRI · 2026
13. Secondary Prevention of Cardiovascular Events in Patients with Overweight/Obesity in Routine Clinical Practice2026
14. Drug Repurposing: Conversion of the Peripherally Restricted HIV Protease Inhibitor Amprenavir to Potent, Selective, and CNS-Penetrant Agonists for the Cannabinoid Receptor 2Journal of Medicinal Chemistry · 2026
15. Discovery of 7-(Pyridin-3-yl)thieno[3,2- b ]pyridine-5-carboxamides as Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5ACS Chemical Neuroscience · 2026
16. Discovery of VU6025733 (AG06827): A Highly Selective, Orally Bioavailable, and Structurally Distinct M ₄ Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM) with Robust In Vivo EfficacyACS Chemical Neuroscience · 2026
17. From light and activity to risk: circadian alignment as an emerging wearable biomarkerEuropean Journal of Preventive Cardiology · 2026
18. Discovery of VU6083859, a TAOK1 Selective Inhibitor, and VU6080195, a pan -TAOK ActivatorACS Chemical Neuroscience · 2026
19. Discovery of VU6052254: A Novel, Potent M ₁ Positive Allosteric ModulatorACS Chemical Neuroscience · 2025
20. Discovery of VU6052254: A Novel, Potent M ₁ Positive Allosteric ModulatorACS Chemical Neuroscience · 2025